Rheumnow Podcast
EULAR 2024 Rheumatology Roundup
Jun 21, 2024
Drs. Kavanaugh and Cush discuss topics from the EULAR 2024 Meeting, including the impact of anxiety on disease activity in RA patients, challenges in treating difficult cases of RA and psoriatic arthritis, recognizing and addressing depression symptoms, and exploring studies on ILD in RA patients. They also cover the use of AI in treatment analysis, CAR-T therapy for autoimmune diseases, and the efficacy of Dukravicitinib in managing lupus skin conditions.
55:32
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Addressing mental health is crucial in rheumatoid arthritis treatment plans.
- Continuing biologic treatment during certain infections lowers serious infectious events in arthritis patients.
Deep dives
Implications of Anxiety and Depression on Rheumatoid Arthritis Patients
An intriguing poster on ultrasound assessment revealed the impact of anxiety and depression on disease activity in rheumatoid arthritis patients. The study included 200 patients starting a biologic DMARD, with 54% reporting moderate to extreme anxiety. Results showed worse patient global scores, pain, fatigue, and HAQ among anxious individuals, despite similar ultrasound results, highlighting the need to address mental health in treatment plans.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
